Tyrosine phosphorylation and CD95: a FAScinating switch.

Area of Science:

• Cell Biology
• Molecular Biology
• Cancer Research

Background:

• Apoptosis, or programmed cell death, is crucial for tissue homeostasis and immune responses.
• Death receptors, characterized by an intracellular Death Domain (DD), initiate apoptotic signaling.
• The CD95 receptor (Fas/Apo-1) is a well-studied death receptor with emerging roles in diverse signaling pathways.

Purpose of the Study:

• To review the current understanding of the CD95/CD95L system.
• To highlight CD95's non-apoptotic signaling roles, including MAPK and NFkB activation.
• To discuss the novel connection between CD95 and the PI3K pathway in Glioblastoma multiforme.

Main Methods:

• Literature review of studies on CD95 signaling.
• Analysis of research on CD95's involvement in MAPK, NFkB, and PI3K pathways.
• Focus on experimental evidence linking CD95 to PI3K in glioblastoma.

Main Results:

• CD95 activates p38, JNK, and ERK MAPK pathways.
• CD95 signaling also leads to the activation of the transcription factor NFkB.
• A novel molecular link between CD95 and the PI3K pathway has been identified in glioblastoma.

Conclusions:

• CD95's function extends beyond apoptosis, impacting cell invasion, neurite outgrowth, and proliferation.
• Understanding CD95's role in PI3K signaling offers new insights into glioblastoma pathogenesis.
• Further research is needed to elucidate the mechanisms and phenotypic consequences of CD95-PI3K crosstalk.